| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aorta, Thoracic | 8 | 2019 | 211 | 2.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 4 | 2017 | 139 | 1.550 |
Why?
|
| Aortic Aneurysm, Thoracic | 7 | 2020 | 134 | 1.500 |
Why?
|
| Aorta, Abdominal | 3 | 2017 | 97 | 1.420 |
Why?
|
| Matrix Metalloproteinases | 5 | 2016 | 223 | 1.250 |
Why?
|
| Matrix Metalloproteinase 2 | 5 | 2016 | 145 | 0.810 |
Why?
|
| Matrix Metalloproteinase 9 | 4 | 2016 | 160 | 0.780 |
Why?
|
| Endovascular Procedures | 3 | 2020 | 366 | 0.770 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2019 | 317 | 0.730 |
Why?
|
| Stathmin | 1 | 2019 | 2 | 0.700 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 38 | 0.680 |
Why?
|
| Femoral Artery | 1 | 2020 | 139 | 0.660 |
Why?
|
| Wound Healing | 1 | 2020 | 260 | 0.600 |
Why?
|
| Patient Discharge | 1 | 2020 | 294 | 0.590 |
Why?
|
| Arterial Pressure | 1 | 2017 | 47 | 0.590 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2020 | 186 | 0.590 |
Why?
|
| Cathepsins | 1 | 2016 | 37 | 0.560 |
Why?
|
| Matrix Metalloproteinase 14 | 3 | 2016 | 44 | 0.560 |
Why?
|
| Interleukin-6 | 1 | 2017 | 330 | 0.530 |
Why?
|
| Arteries | 1 | 2016 | 108 | 0.520 |
Why?
|
| Atherosclerosis | 1 | 2016 | 204 | 0.460 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2013 | 8 | 0.460 |
Why?
|
| Aneurysm, Infected | 1 | 2013 | 16 | 0.450 |
Why?
|
| Saphenous Vein | 1 | 2013 | 61 | 0.450 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2016 | 282 | 0.440 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2014 | 182 | 0.420 |
Why?
|
| Blood Pressure | 1 | 2016 | 1451 | 0.370 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 615 | 0.360 |
Why?
|
| Angiotensin II | 3 | 2017 | 220 | 0.350 |
Why?
|
| Stents | 1 | 2014 | 657 | 0.330 |
Why?
|
| Vasoconstriction | 1 | 2009 | 81 | 0.320 |
Why?
|
| Multiple Trauma | 1 | 2008 | 50 | 0.320 |
Why?
|
| Thoracic Injuries | 1 | 2008 | 44 | 0.310 |
Why?
|
| Stress, Mechanical | 3 | 2017 | 208 | 0.300 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 178 | 0.300 |
Why?
|
| Coronary Artery Bypass | 1 | 2008 | 218 | 0.300 |
Why?
|
| Hypertension | 1 | 2016 | 1535 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2014 | 2324 | 0.290 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 253 | 0.270 |
Why?
|
| Electric Stimulation Therapy | 2 | 2021 | 147 | 0.250 |
Why?
|
| Animals | 10 | 2019 | 20881 | 0.240 |
Why?
|
| Male | 16 | 2021 | 37321 | 0.230 |
Why?
|
| Female | 15 | 2021 | 38074 | 0.230 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 2016 | 85 | 0.230 |
Why?
|
| Risk Factors | 5 | 2020 | 5731 | 0.220 |
Why?
|
| Treatment Outcome | 7 | 2020 | 7029 | 0.220 |
Why?
|
| Spinal Cord Ischemia | 2 | 2020 | 21 | 0.220 |
Why?
|
| Humans | 20 | 2021 | 68618 | 0.220 |
Why?
|
| RNA, Messenger | 4 | 2019 | 1664 | 0.210 |
Why?
|
| MicroRNAs | 2 | 2019 | 447 | 0.210 |
Why?
|
| Retrospective Studies | 7 | 2020 | 7277 | 0.210 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 696 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2550 | 0.210 |
Why?
|
| Dilatation, Pathologic | 3 | 2017 | 58 | 0.200 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 16 | 0.190 |
Why?
|
| Disease Progression | 2 | 2016 | 1038 | 0.190 |
Why?
|
| Middle Aged | 11 | 2020 | 21147 | 0.190 |
Why?
|
| Celiac Artery | 1 | 2020 | 12 | 0.180 |
Why?
|
| Mesenteric Ischemia | 1 | 2020 | 8 | 0.180 |
Why?
|
| Myristoylated Alanine-Rich C Kinase Substrate | 1 | 2019 | 3 | 0.180 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2020 | 20 | 0.180 |
Why?
|
| Punctures | 1 | 2020 | 35 | 0.170 |
Why?
|
| Aged | 8 | 2020 | 14862 | 0.170 |
Why?
|
| Hyperplasia | 1 | 2019 | 89 | 0.170 |
Why?
|
| Mice | 6 | 2019 | 8474 | 0.170 |
Why?
|
| Emergencies | 1 | 2020 | 107 | 0.170 |
Why?
|
| Exome | 1 | 2019 | 20 | 0.160 |
Why?
|
| Aortic Diseases | 1 | 2019 | 113 | 0.160 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 4848 | 0.150 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2017 | 30 | 0.150 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 150 | 0.150 |
Why?
|
| CD11b Antigen | 1 | 2017 | 47 | 0.150 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2017 | 27 | 0.150 |
Why?
|
| Antigens, Differentiation | 1 | 2017 | 49 | 0.150 |
Why?
|
| Time Factors | 4 | 2020 | 4655 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 86 | 0.150 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 101 | 0.150 |
Why?
|
| Cathepsin L | 1 | 2016 | 10 | 0.140 |
Why?
|
| Cathepsin K | 1 | 2016 | 16 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2020 | 402 | 0.140 |
Why?
|
| Antigens, CD | 1 | 2017 | 230 | 0.140 |
Why?
|
| Monocytes | 1 | 2017 | 210 | 0.140 |
Why?
|
| Vascular Remodeling | 1 | 2016 | 34 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2020 | 2007 | 0.140 |
Why?
|
| Rupture, Spontaneous | 1 | 2016 | 21 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2019 | 384 | 0.140 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 144 | 0.140 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2016 | 59 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 64 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2017 | 1200 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2673 | 0.130 |
Why?
|
| Drug Design | 1 | 2016 | 107 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 170 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 183 | 0.120 |
Why?
|
| Models, Anatomic | 1 | 2015 | 51 | 0.120 |
Why?
|
| Aortic Aneurysm | 1 | 2015 | 77 | 0.120 |
Why?
|
| Pseudomyxoma Peritonei | 1 | 2014 | 8 | 0.120 |
Why?
|
| Appendiceal Neoplasms | 1 | 2014 | 9 | 0.120 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2014 | 18 | 0.120 |
Why?
|
| Mucocele | 1 | 2014 | 20 | 0.120 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 23 | 0.120 |
Why?
|
| Macrophages | 1 | 2017 | 647 | 0.120 |
Why?
|
| Ligation | 1 | 2013 | 83 | 0.110 |
Why?
|
| Heredity | 1 | 2013 | 9 | 0.110 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 53 | 0.110 |
Why?
|
| Pedigree | 1 | 2013 | 159 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1293 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 126 | 0.100 |
Why?
|
| Heart Failure | 1 | 2021 | 1180 | 0.100 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 373 | 0.090 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2011 | 31 | 0.090 |
Why?
|
| Vascular Patency | 1 | 2011 | 122 | 0.090 |
Why?
|
| Biomarkers | 1 | 2016 | 1593 | 0.090 |
Why?
|
| Adult | 5 | 2020 | 21403 | 0.090 |
Why?
|
| Aorta | 1 | 2011 | 316 | 0.090 |
Why?
|
| Phenotype | 1 | 2013 | 947 | 0.090 |
Why?
|
| Aortic Valve | 1 | 2011 | 249 | 0.090 |
Why?
|
| Renal Dialysis | 1 | 2011 | 174 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 493 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 786 | 0.090 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2009 | 80 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2019 | 1615 | 0.080 |
Why?
|
| Intestinal Perforation | 1 | 2009 | 35 | 0.080 |
Why?
|
| Pneumoperitoneum | 1 | 2009 | 7 | 0.080 |
Why?
|
| Lac Operon | 1 | 2009 | 54 | 0.080 |
Why?
|
| Contrast Media | 2 | 2010 | 595 | 0.080 |
Why?
|
| Aortic Rupture | 1 | 2008 | 32 | 0.080 |
Why?
|
| Genes, Reporter | 1 | 2009 | 191 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2008 | 42 | 0.080 |
Why?
|
| Rabbits | 1 | 2009 | 509 | 0.080 |
Why?
|
| Prognosis | 1 | 2013 | 2093 | 0.080 |
Why?
|
| Accidents, Traffic | 1 | 2008 | 109 | 0.080 |
Why?
|
| Gastrostomy | 1 | 2009 | 110 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 130 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2009 | 2689 | 0.070 |
Why?
|
| Ventricular Remodeling | 1 | 2010 | 318 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2010 | 481 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 1026 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 1033 | 0.070 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2009 | 348 | 0.070 |
Why?
|
| Endoscopy | 1 | 2009 | 464 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 807 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2019 | 902 | 0.060 |
Why?
|
| Oxidants | 1 | 2004 | 48 | 0.060 |
Why?
|
| Stroke Volume | 2 | 2021 | 586 | 0.060 |
Why?
|
| NADPH Oxidases | 1 | 2004 | 80 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 168 | 0.060 |
Why?
|
| Length of Stay | 2 | 2019 | 780 | 0.050 |
Why?
|
| Baroreflex | 1 | 2021 | 20 | 0.050 |
Why?
|
| Adolescent | 1 | 2013 | 8912 | 0.050 |
Why?
|
| Incidence | 2 | 2019 | 1603 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 101 | 0.050 |
Why?
|
| Insulin | 1 | 2004 | 619 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 5300 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2020 | 11 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 106 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2021 | 483 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 2791 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2019 | 254 | 0.040 |
Why?
|
| Reoperation | 1 | 2019 | 467 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 622 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 1056 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 733 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 2014 | 47 | 0.030 |
Why?
|
| Omentum | 1 | 2014 | 18 | 0.030 |
Why?
|
| Peritoneum | 1 | 2014 | 27 | 0.030 |
Why?
|
| Appendectomy | 1 | 2014 | 47 | 0.030 |
Why?
|
| Colectomy | 1 | 2014 | 64 | 0.030 |
Why?
|
| Quality of Life | 1 | 2021 | 1515 | 0.030 |
Why?
|
| Elastic Tissue | 1 | 2011 | 28 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 179 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 144 | 0.020 |
Why?
|
| Veins | 1 | 2011 | 68 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2011 | 145 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2010 | 25 | 0.020 |
Why?
|
| Microbubbles | 1 | 2010 | 8 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Calcium Chloride | 1 | 2010 | 38 | 0.020 |
Why?
|
| Systole | 1 | 2010 | 149 | 0.020 |
Why?
|
| Diastole | 1 | 2010 | 161 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 546 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 536 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 36 | 0.020 |
Why?
|
| Pacemaker, Artificial | 1 | 2010 | 157 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 281 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2010 | 153 | 0.020 |
Why?
|
| Swine | 1 | 2010 | 672 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 710 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2011 | 287 | 0.020 |
Why?
|
| Heart Rate | 1 | 2010 | 568 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2010 | 453 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 954 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 384 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 682 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1174 | 0.020 |
Why?
|
| Echocardiography | 1 | 2010 | 515 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 772 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2077 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2004 | 13 | 0.010 |
Why?
|
| 3T3-L1 Cells | 1 | 2004 | 30 | 0.010 |
Why?
|
| NADPH Oxidase 4 | 1 | 2004 | 17 | 0.010 |
Why?
|
| South Carolina | 1 | 2011 | 2752 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 56 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 71 | 0.010 |
Why?
|
| Adipocytes | 1 | 2004 | 88 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2004 | 295 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 1196 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 250 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 2358 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 791 | 0.010 |
Why?
|
| Glucose | 1 | 2004 | 307 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2004 | 434 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 742 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 331 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 411 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 5717 | 0.010 |
Why?
|